![PepGen Inc. logo](/logos/PEPG.webp)
PepGen Inc.
NASDAQ:PEPG
Overview | Financials
Company Name | PepGen Inc. |
Symbol | PEPG |
Currency | USD |
Price | 8.83 |
Market Cap | 287,767,077 |
Dividend Yield | 0% |
52-week-range | 3.72 - 19.298 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. James G. McArthur Ph.D. |
Website | https://www.pepgen.com |
An error occurred while fetching data.
About PepGen Inc.
PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is also
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD